CoreAge Rx Review

On October 29, 2026 Trustpilot showed CoreAge Rx at 4.5 out of 5 from 1,504 reviews. When we read the profile again on October 30, 2026 it showed no TrustScore: Trustpilot said the company's rating is unavailable due to a breach of its guidelines, and that it had removed a number of fake reviews for the company. The profile then listed 3,062 reviews, 3,058 of them in the last twelve months: 85% five-star, 6% four-star, 1% three-star, 1% two-star and 7% one-star (Trustpilot's own figures). It showed no claimed date, so we do not state one. Among the handful of one-star reviews we saw on October 29, 2026, the themes were the starting dose not being made clear before payment, so that extra doses cost more than expected, and not being able to sign in or reach anyone by phone. Those are two customers' accounts, not a sample, and we have not audited individual reviews.

The Better Business Bureau has two profiles for the business. The one under the name CoreAge Rx (Wichita Falls, Texas, alternate business name DSO Fine Shrimp LLC) shows an F rating and no BBB accreditation, with 116 complaints in the last 3 years, all of them in the last 12 months (read October 30, 2026). The reasons the BBB gives for the rating include concerns with the business's practices, advertising issues found by the BBB, failure to respond to 5 complaints, 7 complaints that were not resolved, and a failure to resolve the underlying causes of a pattern of complaints. The BBB opened that file on January 7, 2026.

That profile carries two BBB alerts. In the first, the BBB says that on March 3, 2026 it identified a pattern of complaints alleging orders not delivered or long delayed, no way to reach a person in customer support, cards charged before orders shipped, and refunds promised but not received; it says CoreAge did not respond to its letters, and it closed the inquiry on March 31, 2026 as a failure to respond. In the second, an advertising review opened on March 17, 2026, the BBB asked CoreAge to substantiate its business model and licenses, to disclose its full pricing before enrollment, and to support the health-benefit claims made for one of its injectable products, and it says CoreAge had not responded as of April 2, 2026. The BBB also says it removed all reviews from that profile because it could not confirm their authenticity, and its alert urges caution before doing business with the company. These are the BBB's statements, and the complaints are customers' allegations; we have not audited them.

A second BBB profile, under the operating company's name, DSO Fine Shrimp LLC (Sheridan, Wyoming, alternate business name CoreAge Rx), shows an A- rating, no accreditation and 1 complaint, with its file opened on April 8, 2026; the BBB notes that this address appears to be a commercial registered agent rather than a place of business. A complaint count and a review score are different samples and cannot be averaged.

Refunds and cancellation, from CoreAge's own refund policy (read September 23, 2026): before a provider approves your prescription and before it reaches the pharmacy, you can ask to cancel, but any consultation fee already incurred is deducted; if a provider finds you medically ineligible, the medication portion is refunded and the consultation fee is not, because the review has already happened; and once a prescription has been approved and transmitted to the pharmacy, all prescription sales are final, even before anything ships. Canceling a subscription stops future renewals but does not refund an order already processed. The consultation fee itself, and the gap between it and the “no hidden fees” marketing, is set out in its own section below.

Set against the programs we compare it with: MEDVi refunds in full within 72 hours of the start of the term, and TrimRx refunds the unused part of a prepaid plan if asked within 28 days of payment; CoreAge's terms are closer to bmiMD's, where sales are final once the pharmacy has the order. The practical reading is that eligibility is the moment that matters: pay only once you are confident you qualify, because the fee for the review is the part you will not get back. Compounded medications are not FDA-approved.

Sources: CoreAge Rx on Trustpilot (checked October 30, 2026); CoreAge Rx BBB profile (Wichita Falls, Texas) (checked October 30, 2026); DSO Fine Shrimp LLC BBB profile (Sheridan, Wyoming) (checked October 30, 2026).

Checked November 1, 2026 on CoreAge's own product pages. Semaglutide is $79 a month on its semaglutide product page (the home page still says from $99), and tirzepatide is from $129 (checked November 8, 2026). The microdosing versions are from $79 for semaglutide and $129 for tirzepatide, NAD+ is from $93 as an injection or a nasal spray, and sermorelin is from $99. None of the four GLP-1 product pages states a dose cap or says the price is the same at every dose.

On September 23, 2026 the microdosing pair ran the other way from every other program we list: at CoreAge the lower-dose option cost MORE than the standard one, not less. By November 1, 2026 the microdosing product pages list the same starting prices as the standard ones, so that is no longer the case on CoreAge's own pages.

On September 23, 2026 the bigger source of confusion was a separate partner landing page that advertised semaglutide at $79 and tirzepatide at $129. Those were not discounts on the $99 and $149 plans then listed on the main site. They were dose-capped products, and CoreAge said so in its own words: “any dose up to 1.0 mg” for the semaglutide plan and “any dose up to 7.5 mg” for the tirzepatide plan, so a clinician taking you above the cap would take you off that plan. By November 1, 2026 the main product pages list $79 and $129, the figures the partner page had sold as dose-capped plans, and no longer say whether the price holds at every dose.

One limitation on everything above. CoreAge's checkout tiers sit behind a medical qualification form, so we could not price a basket without submitting health information, which we did not do. Every figure here comes from public marketing pages.

Compare these prices across providers: Compounded tirzepatide cost, checked daily · Sermorelin cost per month, compared

• In September 2026 CoreAge's FAQ stated that the price locked in at checkout “stays the same for all future months, regardless of dose increases”; by November 1, 2026 its product pages no longer said whether the price holds at every dose
• Prescribing entities named in full, which most programs we list do not do
• Semaglutide $79 a month on its semaglutide product page (the home page still says from $99), checked November 1, 2026; tirzepatide from $129, checked November 8, 2026
• Free shipping, and no separate membership fee
• A provider consultation fee of $50 to $100 that the refund policy states is non-refundable
• No named pharmacy and no published list of states served

Compounded semaglutide and compounded tirzepatide as weekly injections, lower-dose microdosing versions of both, NAD+ as an injection and as a nasal spray, and sermorelin. CoreAge also sells skincare, an ED product and supplements that sit outside the prescription lines. Treatment is prescribed only where a clinician from one of its named prescribing entities judges it appropriate.

An online qualification form, reviewed by a licensed provider. CoreAge states it charges you before that review happens: its FAQ says payment “locks in your pricing and places you in the pharmacy queue”. The consultation fee is $50 to $100 depending on treatment and is not refunded once the review has begun.

Free standard shipping on prescription orders, stated as arriving in about 2 to 3 business days after the pharmacy ships. CoreAge puts the typical end-to-end time at about 5 to 7 business days, because medical review, documentation and compounding happen first.

CoreAge's product pages carry the lines “UPFRONT PRICING, NO HIDDEN FEES” and “NO MEMBERSHIP FEES”, and its partner landing page says “No Membership Fee. No Hidden Fees. Everything Included”. Its refund policy says something else: “Any applicable provider consultation fee of $50 to $100 is non-refundable, because the medical consultation and eligibility review have already been performed.”

Strictly, both can be true at once. A consultation fee is not a membership fee. But “everything included” is doing work the pricing does not support, and a reader who took the marketing at face value would not expect to pay $50 to $100 on top of the monthly figure.

Now read it next to two other terms. CoreAge charges you before a clinician reviews your case, and says why: payment “locks in your pricing and places you in the pharmacy queue”. And the refund policy states that the consultation fee “may remain non-refundable even if you cancel before pharmacy fulfilment”.

Put together, those mean a reader can pay, be found medically ineligible, and still be out $50 to $100. The medication portion is returned in that case. The fee for the review that turned them down is not. That is the single most important thing to understand before starting an order with CoreAge, and it is the reason this section exists.

Separately, once a prescription has been approved and transmitted to the pharmacy, CoreAge states that all prescription sales are final. That applies even before the medication ships and even if you change your mind.

When we read it on September 23, 2026, CoreAge's partner landing page badged its two dose-capped plans as “68% OFF” on tirzepatide and “58% OFF” on semaglutide. We reported those badges rather than passing them on as savings, because there was nothing published to check them against.

CoreAge published no list price. Not on the landing page, not on its product pages, not anywhere we read on September 23, 2026. There was no struck-through figure beside either badge.

The one other number on that page was $300, and it was not CoreAge's own former price. It appeared in copy about other providers: “with many other programs, that means your monthly bill goes up after the first month. Your bill doubles. Sometimes triples. Suddenly, you are paying $300+ per month.” That was competitor framing, not a compare-at.

The arithmetic did not work either way. If $300 were the reference, $129 would be 57% off and $79 would be 73.7% off, not the 68% and 58% on the badges. For the badges to be accurate the reference prices would have had to be about $403 and $188, and neither figure appeared anywhere on the site. A percentage off nothing is not a saving you can verify, so treat the monthly figure as the price and ignore any such badge. By November 1, 2026 CoreAge's main product pages list $79 and $129 as starting prices, the figures the partner page had sold as dose-capped plans, and no longer say whether the price holds at every dose; we did not re-read the partner page that day.

This is where CoreAge does better than most. Its terms name the operating company as DSO Fine Shrimp LLC, trading as CoreAge Rx, and name all three prescribing entities: M & D Integrations Inc trading as MD Integrations, MDI Medical Group P.C., and MD Integrations & Wellness Provider Group P.A. It states that these are independently owned and operated, and that CoreAge itself “does not provide medical services, does not employ healthcare providers, does not participate in clinical decisions, and does not practice medicine”. Several programs we list name no prescribing entity at all.

The pharmacy is a gap. CoreAge says a prescription is “transmitted to a licensed pharmacy for compounding and fulfillment” and never names it. No individual clinician is named either.

The published address is 1309 Coffeen Avenue, Suite 1200, Sheridan, Wyoming 82801. That address is not an office. It belongs to Wyoming LLC Attorney, formerly Cloud Peak Law Group, a firm that provides company formation and registered agent services, and public business records list roughly 25 companies registered at it, several sharing the same suite number. Using a registered agent is ordinary and lawful for a Wyoming company, and it implies nothing improper. It does mean the published address tells you nothing about where CoreAge operates from, and CoreAge publishes no operating address that does.

States served are a gap too. CoreAge says it serves “multiple states” and that a provider must hold a license in yours. It publishes no list, so the only way to find out is to begin intake.

Checked September 28, 2026 on CoreAge's own pages. CoreAge's sign-up page carries a “FALL SALE, save $350+ automatically” banner behind a three-hour countdown. We loaded that page twice on September 28, 2026, twenty minutes apart. The timer read 2 hours 59 minutes both times, so it resets on each visit rather than counting toward a deadline. No original or crossed-out price appears anywhere on the page, so there is no figure the $350 is measured against and we cannot check it. On the same day, a second CoreAge landing page ran the same offer as a “Summer Sale” at 58% and 68% off, again with no reference price.

The per-dose pricing was a different matter, and in September we could verify it. On September 23, 2026 CoreAge's main site published semaglutide from $99 a month and tirzepatide from $149 a month, both stated as the same price at every dose, and in September CoreAge's partnerships team confirmed that in writing. By November 1, 2026 its product pages list semaglutide from $79 and tirzepatide from $129 (checked November 8, 2026) and no longer say whether the price holds at every dose, so we no longer describe that flat structure as current. Treat the headline saving as marketing and the monthly price on the product page as the number to check.

None of this bears on whether the treatment is appropriate for you, and neither figure changes the monthly prices recorded above.

PCF reviews online programs for comparison purposes only. Provider details, pricing, availability, and medication paths can change. Confirm current terms directly and consult a licensed clinician before making medical decisions.